Late inflammatory reactions in patients with soft tissue fillers after SARS-CoV-2 infection and vaccination: A systematic review of the literature.
COVID-19
SARS-CoV-2
adverse events
soft tissue filler
vaccination
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
revised:
31
12
2021
received:
29
10
2021
accepted:
09
02
2022
pubmed:
13
2
2022
medline:
6
4
2022
entrez:
12
2
2022
Statut:
ppublish
Résumé
Soft tissue fillers are used for cosmetic and reconstructive purposes, and soft tissue filler procedures are among the most common nonsurgical procedures in the USA. Although soft tissue filler procedures are relatively quick and safe, adverse events such as late inflammatory reactions have been reported with every filler product. Infections and vaccinations have been proposed as potential triggers for late inflammatory reactions (LIRs), and it is therefore not surprising that these adverse events have been reported after SARS-CoV-2 infection and vaccination. Therefore, this review aims to give a detailed overview of these cases. A literature search was undertaken on LIRs in patients with a history of soft tissue filler use after SARS-CoV-2 infection or vaccination. This systematic review was reported according to the PRISMA guidelines. We searched the electronic database PubMed from January 2020 to August 2021. Data on patient characteristics, filler characteristics, clinical findings, and treatment options were included. This review included 7 articles with a total of 19 patients with LIRs after SARS-CoV-2 infection or vaccination. Three patients with postinfection LIRs and 16 patients with postvaccination LIRs were reported. These LIRS mainly occurred in females who had HA injections for cosmetic purposes. Three patients with postinfection LIRs had symptoms of facial swelling and/or lip angioedema in a matter of weeks. Sixteen patients reported reactions after SARS-CoV-2 vaccination (13 following Moderna vaccination and 3 after Pfizer vaccination, after both the first and second doses) from 13 hours up to three weeks. These patients presented with similar clinical symptoms as patients with postinfection LIRs. All patients were treated in a conservative manner. This review shows a relationship between LIRs and SARS-CoV-2 infection and vaccination. In the case of vaccination, these adverse events have been reported only after Moderna and Pfizer vaccinations. The reported adverse events are generally minor and self-limiting, and we encourage patients with soft tissue fillers to participate in vaccination programs.
Identifiants
pubmed: 35150192
doi: 10.1111/jocd.14840
pmc: PMC9115339
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1361-1368Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Aesthet Surg J. 2014 Aug;34(6):913-23
pubmed: 24948821
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
Dermatol Ther. 2021 Jan;34(1):e14644
pubmed: 33300274
Pathog Dis. 2014 Apr;70(3):339-46
pubmed: 24482426
JAAD Case Rep. 2021 Apr;10:63-68
pubmed: 33681439
Aesthetic Plast Surg. 2005 Jan-Feb;29(1):34-48
pubmed: 15759096
Aesthetic Plast Surg. 2021 Aug;45(4):1748-1759
pubmed: 33913021
Plast Reconstr Surg. 2006 Sep;118(3 Suppl):7S-14S
pubmed: 16936539
Arch Dermatol Res. 2022 Jan;314(1):1-15
pubmed: 33559733
Dermatol Surg. 2013 Oct;39(10):1474-85
pubmed: 24090257
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Plast Reconstr Surg. 2017 Mar;139(3):613-621
pubmed: 28234833
J Am Acad Dermatol. 2021 Jul;85(1):34
pubmed: 34112378
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e432-e433
pubmed: 33834559
J Cosmet Dermatol. 2021 May;20(5):1557-1562
pubmed: 33735503
Am J Dermatopathol. 2015 Feb;37(2):107-14
pubmed: 25406851
Dermatol Surg. 2001 Feb;27(2):185-91
pubmed: 11207696
Plast Reconstr Surg. 2009 Jun;123(6):1842-1863
pubmed: 19483587
Lupus. 2012 Oct;21(12):1326-34
pubmed: 22952322
Clin Cosmet Investig Dermatol. 2019 Apr 29;12:277-283
pubmed: 31118731
Plast Reconstr Surg Glob Open. 2017 Dec 22;5(12):e1532
pubmed: 29632758
Infect Drug Resist. 2018 Feb 12;11:213-222
pubmed: 29483779
Aesthet Surg J. 2005 Nov-Dec;25(6):625-7
pubmed: 19338870
J Cosmet Dermatol. 2021 May;20(5):1549-1550
pubmed: 33682241
Expert Rev Med Devices. 2013 Nov;10(6):835-53
pubmed: 24164663
Aesthetic Plast Surg. 2012 Aug;36(4):955-63
pubmed: 22437333
Dermatol Surg. 2015 Aug;41(8):929-39
pubmed: 26166260
Dermatol Surg. 2012 Jan;38(1):38-47
pubmed: 22122552
Clin Cosmet Investig Dermatol. 2020 May 18;13:371-378
pubmed: 32547150
Dermatol Surg. 2002 Jun;28(6):484-90
pubmed: 12081676
Lupus. 2009 Nov;18(13):1217-25
pubmed: 19880572
Clin Cosmet Investig Dermatol. 2021 May 31;14:581-589
pubmed: 34103958
Infect Drug Resist. 2019 Feb 20;12:469-480
pubmed: 30863129
Am J Surg Pathol. 1999 Jan;23(1):113-7
pubmed: 9888711
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 May;117(5):617-625
pubmed: 24656730
Clin Infect Dis. 2013 May;56(10):1438-44
pubmed: 23392390
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jan;117(1):105-10
pubmed: 24332334
J Cosmet Dermatol. 2022 Apr;21(4):1361-1368
pubmed: 35150192
J Am Acad Dermatol. 2020 Jul;83(1):86-95
pubmed: 32035107
J Biomed Mater Res. 2001 Jun 15;55(4):523-9
pubmed: 11288080
Dermatol Surg. 2009 Oct;35 Suppl 2:1681-8
pubmed: 19807764
J Oral Pathol Med. 2004 Feb;33(2):115-20
pubmed: 14720198
Aesthet Surg J. 2019 Jun 21;39(Suppl_4):1-27
pubmed: 31226205